detect
pathogen
sequenc
variant
dna
rna
pointofcar
diagnost
approach
valuabl
rapid
clinic
prognosi
recent
time
crispr
base
detect
nucleic
acid
provid
econom
quicker
altern
sequencingbas
platform
often
difficult
implement
field
present
editor
link
uniform
detect
assay
feluda
employ
highli
accur
enzymat
readout
detect
nucleotid
sequenc
identifi
nucleobas
ident
infer
zygos
precis
demonstr
feluda
output
adapt
multipl
signal
detect
platform
quickli
design
deploy
versatil
applic
includ
rapid
diagnosi
infecti
diseas
outbreak
like
biorxiv
preprint
optim
everi
variant
requir
convers
rna
templat
prior
detect
increas
complex
thu
time
taken
diagnosi
taken
togeth
develop
detect
pipelin
base
highli
specif
crispr
protein
direct
bind
cleavag
base
readout
significantli
increas
sensit
detect
reduc
time
cost
crispr
base
diagnost
crisprdx
especi
crucial
pointofcar
poc
applic
complex
experiment
setup
reaction
compon
feasibl
rise
crispr
base
approach
biosens
nucleic
acid
open
broad
diagnost
portfolio
crispr
product
beyond
standard
genom
edit
abil
recent
time
crispr
compon
success
use
detect
wide
varieti
nucleic
acid
target
obtain
pathogen
microorgan
diseasecaus
mutat
variou
biolog
specimen
heart
detect
procedur
lie
properti
crispr
protein
accur
bind
target
dna
rna
undergo
conform
chang
lead
cleavag
target
gener
reporterbas
signal
outcom
enabl
detect
mechan
foolproof
sensit
reproduc
across
larg
varieti
target
accuraci
dna
interrog
subsequ
enzym
activ
extrem
critic
particularli
clinic
decis
made
base
result
current
technolog
reli
use
crispr
compon
nucleic
acid
detect
sens
ident
target
either
substrat
cleavag
mediat
activ
crispr
ribonucleoprotein
rnp
complex
bind
catalyt
inact
rnp
complex
cleavag
outcom
convert
reporterbas
readout
without
signal
amplif
among
crispr
protein
use
far
inact
form
predominantli
employ
detect
dna
sequenc
use
dna
rna
sequenc
approach
strength
limit
relat
sensit
specif
readout
mode
accur
diagnosi
primari
focu
platform
toward
detect
low
copi
number
nucleic
acid
bodi
fluid
patient
signal
amplif
collater
activ
fluoresc
report
proven
advantag
genotyp
individu
high
confid
includ
career
singl
nucleotid
variant
snv
requir
individu
sgrna
design
recent
report
ortholog
francisella
novicida
show
high
mismatch
sensit
vitro
vivo
condit
base
neglig
bind
affin
substrat
harbor
mismatch
properti
distinct
engin
ca
protein
show
similar
high
specif
reason
mediat
dna
interrog
subsequ
cleavag
adapt
accur
identifi
snv
provid
fundament
mechan
discrimin
consist
across
sequenc
figur
name
approach
editor
link
uniform
detect
assay
feluda
demonstr
util
variou
patholog
condit
includ
genet
disord
infecti
diseas
includ
diseas
outbreak
like
covid
identifi
snv
high
accuraci
first
sought
investig
direct
cleav
wild
type
wt
variant
snv
place
addit
mismatch
sgrna
sequenc
specif
snv
test
select
sickl
cell
anemia
sca
global
autosom
recess
genet
disord
caus
one
point
mutat
gag
gtg
identifi
sgrna
recogn
main
diseas
caus
point
mutat
gag
gtg
account
pam
site
vicin
figur
fix
posit
mutat
respect
pam
chang
everi
base
sgrna
sequenc
identifi
combin
led
complet
loss
cleavag
wild
type
substrat
vitro
cleavag
ivc
assay
figur
supplementari
figur
found
two
mismatch
nd
th
posit
away
pam
complet
abrog
cleavag
target
figur
similarli
combin
number
refer
posit
away
pam
also
abolish
cleavag
although
slightli
lower
level
figur
notabl
sca
substrat
mismatch
combin
produc
near
complet
cleavag
suggest
combin
may
favor
discrimin
wt
sca
substrat
figur
importantli
design
principl
guid
allel
discrimin
everi
snv
appear
posit
upstream
trinucleotid
ngg
pam
dna
perform
feluda
synthet
sequenc
correspond
snv
report
mendelian
disord
like
glanzman
thrombasthenia
hemophilia
factor
viii
defici
glycogen
storag
diseas
type
x
link
myotubular
myopathi
observ
ident
pattern
success
discrimin
snv
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
supplementari
figur
taken
togeth
experi
suggest
feluda
design
univers
use
detect
snv
would
requir
extens
optim
valid
step
new
snv
aid
user
quick
design
implement
feluda
target
snv
develop
webtool
jatayu
junction
analysi
target
design
feluda
assay
incorpor
featur
gener
primer
sequenc
amplicon
sgrna
synthesi
http
jatayuigibresin
supplementari
figur
next
test
feluda
dna
sca
patient
healthi
control
found
everi
case
sc
mutat
contain
substrat
cleav
give
distinguish
signatur
wt
substrat
remain
intact
supplementari
figur
establish
enzym
specif
positionspecif
mismatch
respect
pam
site
fundament
reason
discrimin
design
mismatch
combin
cleavag
occur
wt
substrat
observ
ident
result
thu
confirm
hypothesi
supplementari
figur
notabl
simpl
agaros
gel
electrophoresi
employ
discrimin
suggest
feluda
use
routin
molecular
biolog
lab
establish
presenc
snv
dna
sequenc
recent
time
fluoresc
base
nucleic
acid
detect
wide
use
sever
crisprdx
platform
particularli
collater
cleavag
report
employ
although
feluda
result
precis
determin
agaros
capillari
electrophoresi
envis
fluoresc
chemiluminesc
altern
endpoint
readout
expand
scope
devic
suit
feluda
base
detect
implement
first
investig
feluda
adapt
noncleavag
affinitybas
method
detect
work
singl
nucleotid
mismatch
sensit
develop
readout
test
feluda
catalyt
dead
tag
fluorophor
gfp
investig
mismatch
discrimin
regul
level
dna
bind
supplementari
figur
perform
microscal
thermophoresi
mst
assay
measur
bind
affin
inact
rnp
complex
wt
sca
substrat
observ
sca
substrat
show
moder
strong
bind
k
nm
wherea
wt
substrat
exhibit
weak
bind
k
nm
nm
consist
absenc
cleavag
ivc
readout
figur
develop
pipelin
adapt
feluda
affinitybas
fluoresc
readout
system
amplif
step
gener
biotinyl
product
immobil
magnet
streptavidin
bead
upon
incub
fluoresc
compon
feluda
absenc
presenc
mismatch
guid
bind
molecul
substrat
lead
loss
fluoresc
signal
supernat
figur
test
feluda
use
wt
sca
substrat
observ
distinct
signatur
distinguish
two
allel
suggest
feluda
adapt
fluorescencebas
readout
figur
next
investig
feluda
detect
extend
quick
point
care
diagnosi
snv
use
later
flow
strip
instrumentfre
visual
detect
although
readout
demonstr
crispr
effector
collater
activ
reli
secondari
signal
amplif
step
fluoresc
oligo
ad
reaction
setup
design
assay
use
fam
label
rnp
complex
biotin
label
amplicon
commerci
avail
paper
strip
reaction
rnpbound
substrat
molecul
solut
lead
aggreg
complex
distinct
test
line
strip
antifam
antibodi
link
gold
nanoparticl
accumul
control
line
strip
figur
enabl
fam
label
sgrna
first
valid
success
activ
chimer
sgrna
alter
length
overlap
crrna
tracrrna
observ
overlap
effici
cleav
target
figur
sinc
singl
fam
label
tracrrna
compat
multipl
crrna
design
also
reduc
time
cost
feluda
assay
next
perform
assay
hbb
target
abl
detect
femtomolar
level
target
dna
solut
suggest
even
without
signal
amplif
feluda
reach
sensit
similar
report
crisprdx
platform
employ
collater
activ
figur
final
test
feluda
use
wt
sca
sampl
obtain
clear
distinguish
band
either
condit
valid
feasibl
visual
detect
feluda
diagnost
complet
accuraci
figur
genotyp
carrier
individu
heterozygos
though
nonsequenc
pcr
base
method
often
complic
requir
extens
optim
primer
concentr
assay
condit
although
sickl
cell
trait
sct
individu
gener
nonsymptomat
carrier
screen
vital
prevent
spread
sca
success
gener
wide
employ
sca
control
program
variou
part
world
specul
high
specif
feluda
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
extend
identifi
carrier
sinc
would
cleav
dna
copi
carri
sca
mutat
thu
show
intermedi
cleavag
pattern
figur
also
investig
use
saliva
instead
blood
noninvas
sourc
genom
dna
would
allow
genotyp
children
age
subject
draw
blood
may
feasibl
obtain
clear
distinguish
signatur
dna
cleavag
sct
subject
intermedi
normal
sca
individu
suggest
feluda
success
use
determin
zygos
specif
snv
figur
although
reinforc
inher
sensit
feluda
genotyp
target
mismatch
obtain
three
distinct
readout
would
necessit
significantli
robust
reaction
compon
high
reproduc
across
multipl
subject
perform
blind
experi
use
dna
obtain
subject
three
genotyp
tertiari
care
center
remark
feluda
result
perfectli
match
sequenc
data
sampl
perform
differ
laboratori
csir
center
cellular
molecular
biolog
chandak
lab
thu
identifi
three
genotyp
accuraci
figur
although
sever
pathogen
snv
locat
close
ngg
pam
accur
target
feluda
form
small
subset
total
number
diseasecaus
snv
catalogu
clinvar
databas
supplementari
figur
detect
nonpam
proxim
snv
design
inbuilt
pam
site
amplif
step
feluda
test
approach
use
snv
present
helicobact
pylori
rrna
gene
ngg
pam
vicin
snv
confer
variabl
clarithromycin
resist
patient
gastric
ulcer
clinic
pose
seriou
concern
physician
valid
pammer
base
amplif
success
use
base
ivc
target
synthet
dna
sequenc
contain
h
pylori
rrna
gene
figur
isol
bacteria
dna
patient
gut
biopsi
sampl
feluda
reaction
overcom
explor
singl
mismatch
sgrna
sequenc
might
lead
abrog
cleavag
bind
substrat
particularli
posit
pam
distal
end
sinc
show
minimum
cleavag
previou
studi
remark
found
show
neglig
cleavag
posit
supplementari
figur
particular
mismatch
pam
distal
th
base
show
complet
absenc
cleavag
neglig
bind
affin
mismatch
substrat
figur
confirm
strategi
target
snv
associ
either
g
c
gc
heterozyg
variant
differ
individu
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
supplementari
figur
eas
design
implement
exemplifi
urgent
deploy
health
crisi
offer
immens
possibl
rapid
widespread
test
far
proven
success
spread
progress
diseas
multipl
countri
sequenc
hbb
wt
sca
vegfa
site
pcr
amplifi
clone
topota
vector
thermo
fisher
scientif
around
region
around
includ
snvmismatch
four
mendelian
disord
glanzman
thrombasthenia
hemophilia
factor
viii
defici
glycogen
storag
diseas
type
xlink
myotubular
myopathi
procur
synthet
dna
oligo
clone
ecorv
genescript
similarli
region
flank
two
snv
helicobact
pylori
rrna
gene
order
synthet
dna
clone
ecorv
clone
sequenc
confirm
sanger
sequenc
plasmid
construct
use
adapt
previou
studi
vitro
transcript
sgrnascrrna
done
use
megascript
transcript
kit
thermo
fisher
scientif
use
promot
contain
templat
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
substrat
ivt
reaction
incub
overnight
follow
dnase
treatment
per
kit
instruct
purifi
nucaway
spin
column
thermo
fisher
scientif
purif
ivt
sgrnascrrna
store
use
human
genom
dna
extract
blood
use
wizard
genom
dna
purif
kit
promega
per
instruct
genom
dna
extract
saliva
saliva
centrifug
rpm
follow
three
wash
pb
wash
pellet
lyse
triton
minut
centrifug
rpm
supernat
transfer
fresh
vial
total
volum
supernat
use
pcr
reaction
otherwis
store
genom
dna
extract
biopsi
sampl
dna
sampl
directli
pcr
amplifi
target
region
rna
sampl
convert
cdna
use
revers
transcriptas
kit
qiagen
pcr
amplifi
vitro
cleavag
assay
perform
optim
previou
studi
chimer
grna
crrna
tracrrna
prepar
mix
invitro
transcrib
crrna
synthet
label
tracrrna
equimolar
ratio
use
anneal
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
buffer
nacl
trishcl
ph
mgcl
mix
heat
c
minut
allow
cool
room
temperatur
minut
chimer
grnadead
rnp
complex
prepar
mix
buffer
hepe
kcl
dtt
glycerol
mgcl
incub
min
rt
rpa
pcr
amplifi
biotinyl
amplicon
incub
rnp
complex
minut
dipstick
buffer
ad
along
milenia
hybridetect
paper
strip
twistdx
ad
per
instruct
produc
dark
color
band
strip
within
min
complex
prepar
mix
buffer
hepe
kcl
dtt
glycerol
mgcl
incub
min
rt
reconstitut
rnp
complex
along
pcr
amplifi
dna
amplicon
use
ivc
assay
differ
temperatur
rang
minut
reaction
inhibit
use
proteinas
k
ambion
remov
residu
rna
rnase
purelink
cleav
product
visual
agaros
gel
complex
prepar
mix
buffer
hepe
kcl
dtt
glycerol
mgcl
incub
min
rt
linear
plasmid
use
substrat
incub
reconstitut
rnp
complex
differ
time
point
start
h
h
without
sucros
reaction
buffer
respect
cleav
product
visual
agaros
gel
bind
experi
protein
use
along
page
purifi
respect
ivt
sgrna
notabl
ivt
sgrna
purifi
ureapag
bind
affin
protein
sgrna
ribonucleoprotein
complex
target
calcul
use
monolith
nt
nanotemp
technolog
gmbh
munich
germani
rnp
complex
protein
sgrna
molar
form
c
min
reaction
buffer
mm
hepe
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
kcl
dtt
mgcl
target
dna
constitut
duplex
form
use
hplc
purifi
ssdna
oligo
sigma
anneal
min
c
slowli
cool
c
bp
dsdna
differ
genom
target
vari
concentr
rang
incub
rnp
complex
c
min
reaction
buffer
nanotemp
standard
treat
capillari
use
load
sampl
measur
perform
use
led
power
blue
filter
excit
wavelength
emiss
wavelength
mst
power
experi
repeat
least
three
time
measur
data
analys
done
use
nanotemp
analysi
softwar
graph
plot
use
originpro
softwar
sequenc
reaction
carri
use
big
dye
termin
cycl
sequenc
kit
abi
volum
contain
purifi
dna
sequenc
reaction
mix
dilut
buffer
forward
revers
primer
follow
cycl
condit
min
cycl
sec
sec
min
min
subsequ
pcr
product
purifi
mix
edta
ph
incub
rt
min
absolut
ethanol
naoac
ph
ad
incub
rt
min
centrifug
min
follow
invert
spin
discard
supernat
pellet
wash
twice
ethanol
min
supernat
discard
invert
spin
pellet
air
dri
dissolv
hidi
formamid
thermo
fisher
denatur
min
follow
snapchil
link
abi
sequenc
base
call
carri
use
sequenc
analysi
softwar
abi
us
sequenc
analyz
use
chroma
technelysium
australia
clinvar
dataset
version
use
extract
diseas
variat
spectrum
target
feluda
jatayu
jatayuigibresin
web
tool
enabl
user
design
sgrna
primer
detect
variat
user
need
provid
valid
genom
sequenc
posit
type
variat
jatayu
frontend
creat
use
bootstrap
jqueri
backend
pythonbas
flask
framework
use
genom
analysi
tool
bwa
burrowswheel
align
bedtool
oligo
use
studi
list
tabl
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
thank
member
chakraborti
maiti
lab
help
discuss
valuabl
insight
grate
mitali
mukerji
rajesh
pandey
mohd
faruq
present
studi
approv
ethic
committe
institut
genom
step
user
need
provid
mutat
inform
posit
type
mutat
step
confirm
mutat
inform
step
design
sgrna
primer
given
input
sequenc
mutat
one
fluoresc
rnp
bind
target
rnp
dissoci
process
iter
perform
identifi
nucleobas
sequenc
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
